| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $258.9M | +6.9% | +22.9% |
| Cost of Revenue | $67.9M | +12.2% | +27.4% |
| Gross Profit | $191.1M | +5.1% | +21.4% |
| R&D Expense | $83.1M | +5.1% | +18.0% |
| SG&A Expense | $51.5M | +0.0% | -1.6% |
| Operating Income | -$73.3M | +9.1% | +17.7% |
| Pre-tax Income | -$63.5M | +7.7% | +17.4% |
| Income Tax | -$3.2M | -196.6% | -307.3% |
| Net Income | -$60.3M | +16.3% | +23.1% |
| EPS (Basic) | -$0.18 | +18.2% | +28.0% |
| EPS (Diluted) | -$0.18 | +18.2% | +28.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.2M | -46.0% | -36.3% |
| Short-term Investments | $499.6M | -6.2% | +17.7% |
| Accounts Receivable | $198.8M | +10.8% | +20.7% |
| Current Assets | $957.0M | -12.4% | -3.4% |
| Total Assets | $2.43B | +3.5% | +2.7% |
| Current Liabilities | $627.6M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $72.2M | — | — |
| Capital Expenditures | $519K | — | — |
| Investing Cash Flow | -$24.8M | — | — |
| Financing Cash Flow | -$76.3M | — | — |
| Free Cash Flow | $71.7M | — | — |
| +3.3% |
| Total Liabilities | $882.0M | +4.7% | +21.2% |
| Stockholders' Equity | $1.55B | +2.8% | -5.5% |